Published in Women's Health Weekly, November 19th, 2009
"In addition to well-documented roles of gonadotropin-releasing hormone ( GnRH) in hypopituitary ovarian (HPO) axis, the agonistic or antagonistic analogs ( or both) of GnRH have been shown to inhibit the proliferation of a variety of human gynecologic cancers. Thus, in the present study,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly